ADMA Biologics ADMA Current ratio

Current ratio at other companies

AbCellera Biologics Inc.ABCL

12.8×+1.7×

Lifecore Biomedical, Inc.LFCR

3.9×—

AnaptysBio, Inc.ANAB

7.6×-0.7×

Absci CorporationABSI

6.6×+0.9×

Avalo TherapeuticsAVTX

19.3×+6.9×

Apogee Therapeutics, Inc.APGE

32.6×+16.8×

FAQ

What is ADMA Biologics's current ratio?

ADMA Biologics (ADMA) reported current ratio of 7× in Q2 2026.

How has ADMA Biologics's current ratio changed year-over-year?

ADMA Biologics's current ratio increased by 30.8% year-over-year, from 5.3× to 7×.

What is the long-term trend for ADMA Biologics's current ratio?

Over 5 years (2020 to 2025), ADMA Biologics's current ratio has grown at a -2.7% compound annual growth rate (CAGR), from 7.7× to 6.7×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.